Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George R Aronoff

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of the American Society of Nephrology : JASN|December 9, 2004
Safety of intravenous iron in clinical practice: implications for anemia management protocolsGeorge R Aronoff
Seminars in Dialysis|July 1, 2017
The effect of treatment time, dialysis frequency, and ultrafiltration rate on intradialytic hypotensionGeorge R Aronoff
BMJ (Clinical Research Ed.)|July 30, 2005
Dose adjustment in renal impairment: response from Drug Prescribing in Renal FailureGeorge R Aronoff
Nephrology News & Issues|December 5, 2018
Telehealth monitoring decreases missed treatments in new dialysis patientsNaveena Reddy, George R Aronoff
Nephrology News & Issues|March 22, 2014
Balancing ESA and iron therapy in a prospective payment environmentGeorge R Aronoff, Adam E Gaweda
Journal of the American Society of Nephrology : JASN|February 13, 2009
Hemoglobin variability in anemia of chronic kidney diseaseKamyar Kalantar-Zadeh, George R Aronoff
Southern Medical Journal|June 10, 2010
Massive cystic liver in a patient with autosomal dominant polycystic kidney diseaseTanmay S Panchabhai, George R Aronoff
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 15, 2009
Recognizing and reacting to product-related adverse events in hemodialysisRichard A Ward, George R Aronoff
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 25, 2014
Drug prescribing in kidney disease: can't we do better?George R Aronoff, Joel R Aronoff
Clinical Journal of the American Society of Nephrology : CJASN|October 30, 2014
The medical director in integrated clinical care modelsThomas F Parker, George R Aronoff
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of the American Society of Nephrology : JASN|December 9, 2004
Safety of intravenous iron in clinical practice: implications for anemia management protocolsGeorge R Aronoff
Seminars in Dialysis|July 1, 2017
The effect of treatment time, dialysis frequency, and ultrafiltration rate on intradialytic hypotensionGeorge R Aronoff
BMJ (Clinical Research Ed.)|July 30, 2005
Dose adjustment in renal impairment: response from Drug Prescribing in Renal FailureGeorge R Aronoff
Nephrology News & Issues|December 5, 2018
Telehealth monitoring decreases missed treatments in new dialysis patientsNaveena Reddy, George R Aronoff
Nephrology News & Issues|March 22, 2014
Balancing ESA and iron therapy in a prospective payment environmentGeorge R Aronoff, Adam E Gaweda
Journal of the American Society of Nephrology : JASN|February 13, 2009
Hemoglobin variability in anemia of chronic kidney diseaseKamyar Kalantar-Zadeh, George R Aronoff
Southern Medical Journal|June 10, 2010
Massive cystic liver in a patient with autosomal dominant polycystic kidney diseaseTanmay S Panchabhai, George R Aronoff
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 15, 2009
Recognizing and reacting to product-related adverse events in hemodialysisRichard A Ward, George R Aronoff
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 25, 2014
Drug prescribing in kidney disease: can't we do better?George R Aronoff, Joel R Aronoff
Clinical Journal of the American Society of Nephrology : CJASN|October 30, 2014
The medical director in integrated clinical care modelsThomas F Parker, George R Aronoff
Pageof 4